Synapse Open Synapse
Biology

AREG mediates transient hepatocellular carcinoma resistance to receptor tyrosine kinase inhibitors

Cell Reports ·

Lou et al. define the multiple-stage evolutionary trajectory of lenvatinib resistance in hepatocellular carcinoma cell models and identify a transient NF-κB-AREG-EGFR signaling axis that supports early resistance.

Latest from Cell Reports